Literature DB >> 9245547

Enhanced expression of CD31 and CD54 on tonsillar high endothelial venules in IgA nephropathy.

A Kennel-De March1, M C Béné, B Hurault de Ligny, M Kessler, G C Faure.   

Abstract

Abnormalities in the partition of IgA- and IgG-producing cells in the tonsils of patients with IgA nephropathy have been suggested to result from a dysregulation of cell trafficking and homing through high endothelial venules in this lymphoid tissue. In order to document such adhesion anomalies, we used the 36 monoclonal antibodies of the cell adhesion molecules subpanel of the Fifth International Workshop on Leukocyte Differentiation Antigens on frozen sections of tonsils from 10 patients and 15 controls. This allowed us to describe the partition of cell adhesion molecules in human tonsils and to demonstrate a significant enhancement of CD31 and CD54 expression on high endothelial venules of tonsils from patients with IgA nephropathy. These observations are in keeping with the hypothesis of an increased lymphocyte recruitment in tonsils in this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9245547     DOI: 10.1006/clin.1997.4389

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Enhanced expression of L-selectin on peripheral blood lymphocytes from patients with IgA nephropathy.

Authors:  A Kennel-de March; M C Bene; E Renoult; M Kessler; G C Faure; M N Kolopp-Sarda
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

Review 2.  IgA glycosylation and immune complex formation in IgAN.

Authors:  Hitoshi Suzuki; Jan Novak
Journal:  Semin Immunopathol       Date:  2021-09-27       Impact factor: 9.623

Review 3.  New developments in the genetics, pathogenesis, and therapy of IgA nephropathy.

Authors:  Riccardo Magistroni; Vivette D D'Agati; Gerald B Appel; Krzysztof Kiryluk
Journal:  Kidney Int       Date:  2015-09-16       Impact factor: 10.612

4.  Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment.

Authors:  Yasuyuki Nagasawa; Kenichiro Iio; Shinji Fukuda; Yasuhiro Date; Hirotsugu Iwatani; Ryohei Yamamoto; Arata Horii; Hidenori Inohara; Enyu Imai; Takeshi Nakanishi; Hiroshi Ohno; Hiromi Rakugi; Yoshitaka Isaka
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

Review 5.  New insights into the pathogenesis of IgA nephropathy.

Authors:  See Cheng Yeo; Chee Kay Cheung; Jonathan Barratt
Journal:  Pediatr Nephrol       Date:  2017-06-17       Impact factor: 3.714

Review 6.  Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.

Authors:  Jia-Wei He; Xu-Jie Zhou; Ji-Cheng Lv; Hong Zhang
Journal:  Theranostics       Date:  2020-09-15       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.